Details for New Drug Application (NDA): 215230
✉ Email this page to a colleague
The generic ingredient in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is brimonidine tartrate; timolol maleate. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
Summary for 215230
| Tradename: | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE |
| Applicant: | Alembic |
| Ingredient: | brimonidine tartrate; timolol maleate |
| Patents: | 0 |
Pharmacology for NDA: 215230
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Antagonists |
Suppliers and Packaging for NDA: 215230
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 215230 | ANDA | Alembic Pharmaceuticals Limited | 46708-706 | 46708-706-05 | 1 BOTTLE, DROPPER in 1 CARTON (46708-706-05) / 5 mL in 1 BOTTLE, DROPPER |
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 215230 | ANDA | Alembic Pharmaceuticals Limited | 46708-706 | 46708-706-10 | 1 BOTTLE, DROPPER in 1 CARTON (46708-706-10) / 10 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.2%;EQ 0.5% BASE | ||||
| Approval Date: | Aug 25, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
